Follow the Traws Pharma, Inc. share price and the full management transaction log of the company, a listed issuer based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Market capitalisation: €8.2m. The latest transaction was disclosed on 28 April 2026 (Acquisition). Among the most active insiders: Savchuk Nikolay. Every trade is accessible without an account.
21
Insider Decl.
n/a
Thresholds
€847,179
1 ops.
Buy Volume
n/a
n/a
Sell Volume
31Σ signal
Buys €847,179n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Traws Pharma, Inc. es una empresa farmacéutica que cotiza en el mercado XNAS. Se centra en el desarrollo de tratamientos innovadores para diversas enfermedades.